Abstract
This article reviews the applicability of international human rights law to the regulation of international trade of genetically modified organisms (GMO) that may have adverse effects on human life and health. Rights to life and health are recognised by many international agreements as fundamental human rights. This article argues, from the perspective of the New Haven school of jurisprudence, that since the principle of human dignity as a legal source of fundamental human rights is a basic norm justifying all legal regulations and institutions, it must, in case of conflicts with provisions under the GATT/WTO Agreements, have priority over rules for free trade and investment liberalisation. In light of the rights to life and health being core human rights having the status of international custom or jus cogens, the author proposes several policy and legal requirements to ensure human dignity, as applied to regulations of international trade of GMO.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
